
A new study in JAMA Network Open finds that suicide remains a top cause of death among medical residents — especially in their first months of training.

A new study in JAMA Network Open finds that suicide remains a top cause of death among medical residents — especially in their first months of training.

As Trump and Congress debate the Big Beautiful Bill, public health, medical research, and Medicaid could ‘Make America Healthy Again’ — if the nation pays for them.

Medtronic announces a diabetes business spinoff to enhance focus on growth areas, aiming for improved financial performance and shareholder value.

ReGelTec's HYDRAFIL System offers a minimally invasive treatment for chronic low back pain, promising significant pain relief and improved function.

Biden reveals aggressive prostate cancer that has metastasized to his bones.

HHS announces plan to create ‘most-favored-nation’ cost scale so U.S. is not subsidizing drug prices in other countries.

Avoid regret: 10 things every physician should know before choosing an electronic health record (EHR) platform.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

A new national report finds primary care physicians diagnose 41% of pediatric major depressive disorder cases, often before crisis hits.

Remote support is helping primary care practices reduce administrative stress, allowing physicians to focus more on patient care.

How do hospice services for end of life align with value-based care? Here’s what primary care physicians should know.

Atia Vision's OmniVu lens system promises a breakthrough in cataract surgery with enhanced vision restoration.

The former president likely will have drug therapy to lower his testosterone levels, but there are other treatment options.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.


An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

Daniel Isaac, DO, MS, an oncologist/hematologist, discusses the publicly disclosed diagnosis of prostate cancer in former President Joe Biden.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

Lack of awareness leads many to overlook these potent financial tools

A new study in JAMA Health Forum finds women primary care physicians earn more under value-based models — while delivering better outcomes and fewer hospital visits.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.

U.S. tariffs are disrupting European medtech growth, forcing firms to adapt supply chains and prioritize cost optimization amid rising challenges and uncertainties.

APC CEO Scott Brunner, CAE, discusses compounding drugs, including the GLP-1 RA antidiabetes and antiobesity medications.